The bradykinin-forming cascade and its role in hereditary angioedema

Bradykinin is the mediator of swelling in types I and II HAE and is overproduced because of a deficiency in C1 inhibitor. Inhibition of bradykinin formation by novel agents can provide targeted therapeutic approaches that address the pathophysiologic abnormalities.